Member Info for Sparks21

Hi Katie. These are from my investment notes: Feb update: CEO commits to 2 years to help turnaround and a 250m buy back, which will increase EPS etc by around 5% anyway. March: SP at 1270 as it levels off. There is a lack of guidance and the delays on US manufacturing site, especially as they reduce EURO sites, have dragged the price down. Margin reduction due to more sales in the poorer countries. I feel this is a contrarian entry point. I believe in the growth story as numerous drugs come off patent. Patience is key. Good luck and as always: DYO research.

So we have over £15m to go on the next phase of buy backs and nice to see confirmation that these will be cancelled. This should make a nice difference to the EPS etc.

Really? Upgrade in guidance and profit is up 12%. Sounds good to me.

Oil up 6.3% today. Oil up this high is normally a sign Trump does something to bring the price down. Cue the negotiations.

With the Mcap at approx 75% discount to Tangible book value of 693m then I had to take a punt. Seems priced to fail but I imagine sorting out the covenants will be straight forward and they may need to shift a few assets at a discount to keep things ticking over during this part of the cycle/turnaround. This looks like a takeover target now. Just opinion. Would be nice to see some directors put some skin in the game at these prices now. DYO & GLA.

Topped up this afternoon as out of about 20 shares I own this was the only non energy stock not to bounce. My buy appears as a sell on here. Hopefully next weeks results get this off and rolling. The graph look primed for a recovery and we are very close to our year low despite the positive Iran news. GLA.

Big Mac: Trading Statement on the 23rd April. I imagine this will help set the direction of the SP either way.

At a market cap of £2.31bn, Profit after tax for 2026 of £200m is easily achievable and implies:

P/E ≈ 11.5

Cash-adjusted P/E ≈ 9–10 (because they run £400m+ net cash)

EV/EBIT extremely low for a company with this quality of earnings

Market is re‑rating it. Patience is key. 5500 hopefully in the next 3 to 6 months. In a year or two this could be knocking on the door of the FTSE 100.

Reassuring. Momentum. Seemingly a solid investment that just keeps delivering.

Active Funds may be starting to front buy this if they feel it is likely to move into the Ftse 250. They know the passive flows will follow entry. Shorts exciting and thin liquidity could see this continue to climb hopefully.

What's occurring here then? Surely that short reduction isn't enough for this lift. One of my few blue shares today.

Couldn't resist another top up around the 88p mark. Hopefully will be back in the mid 90 plus by the end of this month and a dividend coming too.

Not enough troops for a ground invasion but maybe they are looking to capture the Uranium. That's what started this all. Or Kharg island though this might be a bluff. And from a "this war is done" strategy, taking Kharg island does not correlate. Taking the island will likely mean destroying the island. This will not impress Trumps allies and will drag this out for years.

Just to let everyone know: Bellway shares are now on sale in the great Spring clearance.

Buy back over dividends has my vote. Better long term option and supportive of the share price.

Taco looks unlikely with todays ultimatum to me. Perhaps this is all about looking for a reason to destroy their power stations (which is not really how civilised nations conduct war) along with being able to blame the Iranian regime for it. After which, if it takes place, Iran retaliates and then hopefully Trump will calls it a day. Well done USA. 90 million people without power. What a catastrophe.

Good results at Moonpig should bode well for us. Their shares are up 6% on decent results and the effect on EPS of their buyback.

I see interactive investor have adjusted their fair value on this share from 22p earlier in March to 31p now.

Brutal end of play today. Topped up at 94p. Balls of steel or an absolute donkey. 2027 is the year of the Wimps! Usual caveats.

Yes, I imagine. Margin compression could continue although if the volume is significantly expanded then this should still see good growth in the bottom line. If a company like this can't thrive right now, as CEO's rush into AI, then when will it ever thrive!!